Reference value for cardiac troponin I in a multi-ethnic group

References

• Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–969.
   PubMed Web of Science ®Google Scholar
• Morrow DA, Cannon CP, Rifai N, et al Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001; 286: 2405–2412.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Alloggiamento T, Melsop K, et al The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001; 38: 478–485.
   PubMed Web of Science ®Google Scholar
• Luepker RV, Apple FS, Christenson RH, et al Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003; 108: 2543–2549.
   PubMed Web of Science ®Google Scholar
• Apple FS, Wu AHB, Jaffe AS. Implementation of the ESC/ACC guidelines for redefinition of myocardial infarction using cardiac troponin assays with special attention to clinical trial issues. Am Heart J 2002; 144: 981–986.
   PubMed Web of Science ®Google Scholar
• Newby LK, Alpert JS, Ohman EM, Thygesen K, Califf RM. Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. Am Heart J 2002; 144: 957–980.
   PubMedGoogle Scholar
• Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH; National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage. Laboratory Medicine Practice Guidelines: analytical issues for bio- chemical markers of acute coronary syndromes. Circulation 2007; 115: e352–e355.
   PubMedGoogle Scholar
• Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000; 102: 1221–1226.
   PubMed Web of Science ®Google Scholar
• Katrukha A, Bereznikova A, Filatov V, et al Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998; 44: 2433–2440.
   PubMed Web of Science ®Google Scholar
• Katrukha A, Bereznikova A, Filatov V, Esakova T. Biochemical factors influencing measurement of cardiac troponin I in serum. (Review). Clin Chem Lab Med 1999; 37: 1091–1095.
   PubMed Web of Science ®Google Scholar
• Katrukha A, Bereznikova A, Esakova T, et al Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997; 43: 1379–1385.
   PubMed Web of Science ®Google Scholar
• James S, Flodin M, Johnston N, Lindahl B, Venge P. The antibody configurations of cardiac troponin I assays may determine the clinical performance. Clin Chem 2006; 52: 832–837.
   PubMed Web of Science ®Google Scholar
• Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49: 1331–1336.
   PubMed Web of Science ®Google Scholar
• Prontera C, Fortunato A, Storti S, et al Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay. Clin Chem 2007; 53: 1722–1723.
   PubMed Web of Science ®Google Scholar